Search by Drug Name or NDC

    NDC 27437-0206-05 SUPRAX 200 mg/5mL Details

    SUPRAX 200 mg/5mL

    SUPRAX is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is CEFIXIME.

    Product Information

    NDC 27437-0206
    Product ID 27437-206_ddcc8926-f489-4ea1-93eb-e959ea8f2e1f
    Associated GPIs 02300060001920
    GCN Sequence Number 044428
    GCN Sequence Number Description cefixime SUSP RECON 200 MG/5ML ORAL
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 92368
    HICL Sequence Number 003999
    HICL Sequence Number Description CEFIXIME
    Brand/Generic Brand
    Proprietary Name SUPRAX
    Proprietary Name Suffix n/a
    Non-Proprietary Name cefixime
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/5mL
    Substance Name CEFIXIME
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065355
    Listing Certified Through 2024-12-31

    Package

    NDC 27437-0206-05 (27437020605)

    NDC Package Code 27437-206-05
    Billing NDC 27437020605
    Package 25 mL in 1 BOTTLE (27437-206-05)
    Marketing Start Date 2007-06-01
    NDC Exclude Flag N
    Pricing Information N/A